India · Delayed Price · Currency is INR Fredun Pharmaceuticals Statistics
Total Valuation
BOM:539730 has a market cap or net worth of INR 24.37 billion. The enterprise value is 26.35 billion.
| Market Cap | 24.37B |
| Enterprise Value | 26.35B |
Important Dates
The next confirmed earnings date is Monday, November 16, 2026.
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | Jun 23, 2026 |
Share Statistics
BOM:539730 has 16.54 million shares outstanding. The number of shares has increased by 24.95% in one year.
| Current Share Class | 16.54M |
| Shares Outstanding | 16.54M |
| Shares Change (YoY) | +24.95% |
| Shares Change (QoQ) | +135.99% |
| Owned by Insiders (%) | 38.93% |
| Owned by Institutions (%) | 3.83% |
| Float | 10.10M |
Valuation Ratios
The trailing PE ratio is 53.29.
| PE Ratio | 53.29 |
| Forward PE | n/a |
| PS Ratio | 2.81 |
| PB Ratio | 7.38 |
| P/TBV Ratio | 7.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 152.96 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 54.74 |
| EV / Sales | 3.04 |
| EV / EBITDA | 20.81 |
| EV / EBIT | 23.06 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.76.
| Current Ratio | 1.65 |
| Quick Ratio | 0.45 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 2.00 |
| Debt / FCF | n/a |
| Interest Coverage | 2.81 |
Financial Efficiency
Return on equity (ROE) is 19.74% and return on invested capital (ROIC) is 14.82%.
| Return on Equity (ROE) | 19.74% |
| Return on Assets (ROA) | 11.54% |
| Return on Invested Capital (ROIC) | 14.82% |
| Return on Capital Employed (ROCE) | 26.39% |
| Weighted Average Cost of Capital (WACC) | 9.16% |
| Revenue Per Employee | 11.77M |
| Profits Per Employee | 653,939 |
| Employee Count | 736 |
| Asset Turnover | 1.40 |
| Inventory Turnover | 2.18 |
Taxes
In the past 12 months, BOM:539730 has paid 273.23 million in taxes.
| Income Tax | 273.23M |
| Effective Tax Rate | 36.21% |
Stock Price Statistics
The stock price has increased by +185.91% in the last 52 weeks. The beta is 0.87, so BOM:539730's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +185.91% |
| 50-Day Moving Average | 1,425.14 |
| 200-Day Moving Average | 939.06 |
| Relative Strength Index (RSI) | 54.05 |
| Average Volume (20 Days) | 14,967 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:539730 had revenue of INR 8.66 billion and earned 481.30 million in profits. Earnings per share was 27.66.
| Revenue | 8.66B |
| Gross Profit | 2.15B |
| Operating Income | 1.14B |
| Pretax Income | 754.53M |
| Net Income | 481.30M |
| EBITDA | 1.27B |
| EBIT | 1.14B |
| Earnings Per Share (EPS) | 27.66 |
Balance Sheet
The company has 553.68 million in cash and 2.53 billion in debt, with a net cash position of -1.97 billion or -119.34 per share.
| Cash & Cash Equivalents | 553.68M |
| Total Debt | 2.53B |
| Net Cash | -1.97B |
| Net Cash Per Share | -119.34 |
| Equity (Book Value) | 3.30B |
| Book Value Per Share | 195.51 |
| Working Capital | 2.22B |
Cash Flow
In the last 12 months, operating cash flow was 159.33 million and capital expenditures -947.18 million, giving a free cash flow of -787.85 million.
| Operating Cash Flow | 159.33M |
| Capital Expenditures | -947.18M |
| Depreciation & Amortization | 123.69M |
| Net Borrowing | 516.95M |
| Free Cash Flow | -787.85M |
| FCF Per Share | -47.64 |
Margins
Gross margin is 24.85%, with operating and profit margins of 13.19% and 5.56%.
| Gross Margin | 24.85% |
| Operating Margin | 13.19% |
| Pretax Margin | 8.71% |
| Profit Margin | 5.56% |
| EBITDA Margin | 14.61% |
| EBIT Margin | 13.19% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 0.02%.
| Dividend Per Share | 0.23 |
| Dividend Yield | 0.02% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 1.69% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -24.95% |
| Shareholder Yield | -24.94% |
| Earnings Yield | 1.88% |
| FCF Yield | -3.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 16, 2026. It was a forward split with a ratio of 3.
| Last Split Date | Jul 16, 2026 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |